AspenBio Pharma is an in vitro diagnostic company focused on the clinical development and commercialization of its lead product AppyScore, a blood-based test designed to aid in the identification of patients at low risk for acute appendicitis. APPY is focused on obtaining FDA clearance and European CE Mark Clearance for the product. The company’s current operations are directed toward the use of AppyScore in children and adolescent patients. For more information visit the company’s Web site at www.aspenbiopharma.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: